Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...
Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...
WISN 12 News on MSN
Mother charged after 12-year-old boy dies from starvation
Mother charged after 12-year-old boy dies from starvation ...
Atossa's Rare Pediatric Disease Designation for (Z)-endoxifen in neuromuscular diseases qualifies for a future PRV upon FDA approval SEATTLE, Feb. 5, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc.
A milestone in the treatment of Duchenne muscular dystrophy (DMD) passed recently with remarkably little public notice. That ...
With a clutch of key data and planned regulatory applications this year from Avidity Biosciences, REGENXBIO and Capricor ...
Wigan Today on MSN
Run Wigan Festival medals are unveiled as entries pour in for half marathon, 5k and family mile
The medals have been revealed ahead of this year’s Run Wigan Festival.
Sarepta Therapeutics (NasdaqGS:SRPT) reported positive three year functional results from its Phase 3 EMBARK trial of Elevidys in ambulatory Duchenne muscular dystrophy patients. The data show slowed ...
Statistics show first-cousin marriages roughly doubles the risk of congenital defects and genetic disorders in children.
The Consolidated Appropriations Act of 2026, signed by Trump on Feb. 3, includes a provision reinstating the Mikaela Naylon ...
Justice was born on Sept. 20, 2006, with a muscle-wasting disease called Duchenne Muscular Dystrophy. He was able to walk until he was between 11 or 12 years old and then had to use a wheelchair to ...
A quiet backyard suddenly burst into song with the stirring brass of John Williams Star Wars theme recently, transforming a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results